ELANCO ANIMAL HEALTH INC ELAT 深 滬
等待開盤 04-02 09:30:00 美东时间
21.32
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 21.32
- 總市值 105.53亿
- 52周最高 42.58
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 17.355
- 委 比 0.00%
- 總股本 4.95亿
- 歷史最高 52.25
- 量 比 0
- 振 幅 0.00%
- 歷史最低 17.355
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Elanco Animal Health Says David Hoover Retires As A Member Of Elanco Board
BRIEF-Elanco Animal Health Says David Hoover Retires As A Member Of Elanco Board Feb 13 (Reuters) - Elanco Animal Health Inc ELAN.N : ELANCO ANIMAL HEALTH INC - DAVID HOOVER RETIRES AS A MEMBER OF ELANCO BOARD ELANCO ANNOUNCES UPDATES TO BOARD OF DIRECTORS Further company coverage: ELAN.N (( Reuters
02-13 22:32
CORRECTED-BRIEF-Elanco Animal Health ELANCO ANIMAL HEALTH FY INNOVATION REV TARGET $840 MLN TO $880 MLN
• ELANCO ANIMAL HEALTH OUTLOOK 2026 INNOVATION REVENUE USD 1,100 MILLION
2025-12-09 20:40
BRIEF-Acadia Healthcare Appoints Todd Young As Chief Financial Officer
Oct 7 (Reuters) - Acadia Healthcare Company Inc ACHC.O: ACADIA HEALTHCARE APPOINTS TODD YOUNG AS CHIEF FINANCIAL OFFICER ACADIA HEALTHCARE COMPANY INC: TODD YOUNG MOST RECENTLY SERVED AS CFO AT ELANCO...
2025-10-08 04:40
BRIEF-Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language
Sept 23 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO ANNOUNCES FDA APPROVES IMPROVED ZENRELIA™ (ILUNOCITINIB TABLETS) LABEL, REMOVING VACCINE-INDUCED DISEASE LANGUAGE ELANCO ANIMAL HEALTH INC -...
2025-09-23 18:30
BRIEF-S&P Dow Jones Indices Elanco Animal Health Set To Join S&P Midcap 400 Sarepta Therapeutics To Join S&P Smallcap 600
Aug 26 (Reuters) - S&P DOW JONES INDICES: ELANCO ANIMAL HEALTH SET TO JOIN S&P MIDCAP 400; SAREPTA THERAPEUTICS TO JOIN S&P SMALLCAP 600 ((Reuters.Briefs@thomsonreuters.com;))
2025-08-27 06:01
BRIEF-Elanco Secures Approval Of Zenrelia(Ilunocitinib) In The European Union (EU)
July 24 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO SECURES APPROVAL OF ZENRELIA™ (ILUNOCITINIB) IN THE EUROPEAN UNION (EU), LAUNCHING INNOVATIVE CANINE DERMATOLOGY TREATMENT FOR ITCHY DOGS EL...
2025-07-25 06:05
BRIEF-Elanco Receives USDA Nod For Trucan Ultra Civ Canine Flu Vaccine
July 9 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO RECEIVES USDA APPROVAL FOR TRUCAN™ ULTRA CIV H3N2/H3N8 (CANINE INFLUENZA VACCINE) BRINGING TO MARKET A HIGH STANDARD OF RESPIRATORY PROTECTIO...
2025-07-09 20:48
BRIEF-Elanco Animal Health Enters First Amendment To Receivables Loan Agreement - SEC Filing
June 26 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO ANIMAL HEALTH INC - ENTERS FIRST AMENDMENT TO RECEIVABLES LOAN AGREEMENT - SEC FILING ELANCO ANIMAL HEALTH INC - FIRST AMENDMENT EXTENDS AGR...
2025-06-27 04:59
BRIEF-Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown
May 5 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO SELLS ROYALTY AND MILESTONE RIGHTS FOR LOTILANER IN HUMAN HEALTH TO BLACKSTONE; ACCELERATES DEBT PAYDOWN ELANCO ANIMAL HEALTH INC - SELLS ROYA...
2025-05-05 18:28
BRIEF-Elanco Animal Health announces changes to board of directors
March 17 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO ANNOUNCES CHANGES TO BOARD OF DIRECTORS; SIGNS RESEARCH AGREEMENT TO EXPLORE NOVEL THERAPIES FOR CHRONIC KIDNEY DISEASE AND LIFE EXTENSION ...
2025-03-18 05:39
